Cefazolin Dosing for Gram-Negative Bacteremia
For gram-negative bacteremia in adults with normal renal function, administer cefazolin 2 grams IV every 8 hours, with dose adjustments required for any degree of renal impairment to prevent neurotoxicity and ensure adequate bacterial killing.
Standard Dosing in Normal Renal Function
The FDA-approved dosing for severe infections including bacteremia is 1-2 grams every 6-8 hours 1. For gram-negative bacteremia specifically, I recommend the higher end of this range:
- 2 grams IV every 8 hours for most gram-negative bacteremia
- This provides optimal time above MIC (T>MIC), the critical pharmacodynamic parameter for beta-lactams 2
The guideline for intra-abdominal infections supports cefazolin 1-2 grams every 8 hours 3, though this represents a lower-severity infection context than bacteremia.
Critical Renal Dose Adjustments
Cefazolin requires mandatory dose reduction in renal impairment - failure to adjust can result in severe neurotoxicity including seizures 4. The FDA label provides specific guidance 1:
Creatinine Clearance-Based Dosing:
- CrCl ≥55 mL/min: Full dose (2g every 8 hours)
- CrCl 35-54 mL/min: Full dose but extend interval to every 8 hours minimum (consider every 12 hours)
- CrCl 11-34 mL/min: Half the usual dose every 12 hours (1g every 12 hours)
- CrCl ≤10 mL/min: Half the usual dose every 18-24 hours (1g every 18-24 hours)
Always give an appropriate loading dose first regardless of renal function 1. For severe bacteremia, this would be 2 grams IV.
Pharmacokinetic Considerations
Recent population pharmacokinetic data demonstrates that absolute glomerular filtration rate (aGFR) is the primary determinant of cefazolin clearance 5. The study showed:
- To achieve target concentrations of 40 mg/L with 90% success:
- aGFR 30 mL/min: 2.6 g/day
- aGFR 60 mL/min: 4.3 g/day
- aGFR 90 mL/min: 6.1 g/day
- aGFR 120 mL/min: 8.0 g/day
This confirms that patients with preserved or augmented renal clearance may require higher doses than standard to achieve adequate exposure 5.
Neurotoxicity Risk
Cefazolin has significant pro-convulsive activity - approximately 3 times that of penicillin G 6. Risk factors for neurotoxicity include:
- Renal dysfunction (most critical)
- Advanced age
- Pre-existing CNS disease
- Supratherapeutic dosing
A case report documented fatal seizures in an 87-year-old with renal dysfunction receiving 2g every 4 hours when dosing should have been 2g every 12 hours 4. This underscores the absolute necessity of renal dose adjustment.
MIC Considerations for Gram-Negatives
For Enterobacterales (E. coli, Klebsiella, Proteus), cefazolin remains effective at MIC ≤8 μg/mL, though there is a trend toward increased treatment failure at MIC of 8 μg/mL compared to ≤4 μg/mL 7. Ensure susceptibility testing confirms MIC ≤8 μg/mL before using cefazolin for gram-negative bacteremia.
Practical Dosing Algorithm
- Confirm susceptibility: MIC ≤8 μg/mL for Enterobacterales
- Calculate CrCl using Cockcroft-Gault or estimate GFR
- Loading dose: 2 grams IV regardless of renal function
- Maintenance dosing:
- Normal renal function (CrCl ≥55): 2g IV q8h
- Mild impairment (CrCl 35-54): 2g IV q12h
- Moderate impairment (CrCl 11-34): 1g IV q12h
- Severe impairment (CrCl <10): 1g IV q18-24h
- Monitor: Daily renal function, mental status changes
Common Pitfalls
- Failing to adjust for renal dysfunction - the most dangerous error leading to neurotoxicity
- Using cefazolin for Pseudomonas or other non-Enterobacterales gram-negatives (not covered)
- Underdosing in patients with augmented renal clearance (critically ill, young patients)
- Not obtaining susceptibility data before definitive therapy